Advertisement
News
Advertisement

Cleveland HeartLab pulls in $15M | Wall Street Beat

Thu, 11/01/2012 - 1:53pm
Mass Device

Cleveland HeartLab raises nearly $15 million for its CardioMPO test for cardiac inflammation.

MassDevice.com Wall Street Beat

Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.

The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic's center for cardiovascular diagnostics and prevention.

Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading